Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s
Fatty molecules also found in UPFs seen at high levels in colorectal tumours
Research intensifies debate over health risks of mass-produced goods made more palatable for consumers
Abingworth wants to pursue royalty-based partnerships with major pharma groups
This is a time for treating people as individuals rather than as members of a tribe
Africa leads decline but cases must fall faster to meet target of ending designation of Aids as public health threat by 2030
Jay Bhattacharya at the NIH would be the latest ally of Robert F Kennedy Jr to take a role overseeing US healthcare
Effort to understand cellular functions promises to unlock crucial information about personal health
Robert F Kennedy Jr’s appointment is characteristic of Trump’s hostility to expertise
Danish company expects data to show that CagriSema cuts weight by 25 per cent in just over a year
New York Times has sued European Commission over its refusal to release president’s exchanges with Pfizer chief
Sharp rise in cases over 30 years compounded by millions of people lacking access to medication, Lancet study finds
People prone to breast cancer and diabetes among beneficiaries of early testing
Initiative is part of growing international efforts to give early warning of pandemic threats
Abbott Laboratories’ ‘virus hunters’ are tracking disease risks exacerbated by climate change
Also in today’s newsletter, can biodiversity credits avoid the blowback that’s hit the carbon credit market?
Potential wider uses should maintain investor enthusiasm and fuel ongoing competition
Since last October, the families of every fallen soldier have been offered postmortem sperm retrieval
Treating today’s mental and physical conditions may be a challenge, but their prevalence is actually a good sign
In this monthly series, running alongside our existing Tech Exchange dialogues, FT journalists talk to the scientists, developers and business leaders exploring ever more applications for artificial intelligence, in every aspect of our lives
French pharma group to take €300mn stake in radiopharmaceuticals company
Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetes
Awards for Sir Demis Hassabis, John Jumper and Geoffrey Hinton recognise how AI is changing our world
It is too early to know whether the prompt response to the virus is enough to turn the tide
Also in this newsletter: How greener corporate car fleets could boost competitiveness and the climate goals
